Skip to main content

Reefer Madness 2.0: Science vs. Policy — When the Healers Speak and the Enforcers Stall

 

Tenn Canna Publishing

Reefer Madness 2.0: Science vs. Policy — When the Healers Speak and the Enforcers Stall





How HHS and FDA medical evaluations clash with DEA inaction — a modern battle of words in federal cannabis policy.

Read the series from the beginning: Reefer Madness 2.0: The War of Words Begins

HHS / FDA Scientific Findings

On August 29, 2023, the Department of Health and Human Services (HHS) submitted a scientific evaluation recommending that cannabis be rescheduled to Schedule III. The report stated:

“HHS … found that marijuana has a potential for abuse less than the drugs or other substances in Schedules I and II; that marijuana has a currently accepted medical use; and that the abuse of marijuana may lead to moderate or low physical dependence or high psychological dependence.”
— HHS Scientific Evaluation Letter to DEA, 2023

This was a clear, evidence-based recommendation supporting medical use. Modern research and decades of state legalization programs confirm these findings.

DEA / Enforcement Reality

Despite the HHS recommendations, the DEA continues to maintain that cannabis has “no currently accepted medical use,” creating a direct conflict between science and policy:

“Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis)… Schedule I drugs … are defined as drugs with no currently accepted medical use and a high potential for abuse.”
— DEA Drug Scheduling, 2025

Recent reporting highlights the ongoing stall:

“The Drug Enforcement Administration said … the marijuana rescheduling process remains stalled … despite the head of agency’s prior commitment to senators that he would prioritize the issue if confirmed for the role.”
— Marijuana Moment, 2025
“Marijuana has been ‘legalized’ and/or ‘decriminalized’ at the state level … as of January 2024 …”
— DEA 2025 National Drug Review

War of Words: Highlighting Contradictions

  • HHS: “Currently accepted medical use.”
    DEA: “No accepted medical use.”
  • HHS: “Abuse potential is lower than Schedule I/II drugs.”
    DEA: “High potential for abuse.”
  • HHS: “Rescheduling recommended.”
    DEA: “Process remains stalled.”

By letting their own words collide, the contradictions are clear — the science is settled, yet the gatekeepers remain in stasis.

Actionable Angle for Readers

  • Track official HHS/FDA reports vs. DEA statements.
  • Compare federal contradictions with real-world state legalization outcomes.
  • Document and share clear “War of Words” examples to expose the gap between evidence and enforcement.

Next in the Series

Attorney General / Executive Branch: Who has the final say on scheduling, the political leverage points, and how their statements reveal obstacles to reform.

🧭 Explore Tennessee Cannabiz Related Posts

© Tenn Canna Publishing — Reefer Madness 2.0 Series | Author: Tenn Canna Publishing

Labels:

Comments

Post a Comment

People's Choice

Tennessee HB 1376 Explained: New Hemp-Derived Cannabinoid Laws, THCa Ban, and What Changes in 2026

  Tennessee HB 1376 ushers in a new regulatory era for hemp-derived cannabinoids , banning THCa products and placing intoxicating hemp under alcohol-style oversight in 2026. Jump Index Introduction to HB 1376 Background and Legislative History Key Provisions Definitions Regulatory Changes & Allowed Activities Prohibitions Licensing Requirements Taxes Penalties & Enforcement Impacts on Stakeholders Pros and Cons Conclusion Introduction to HB 1376 Tennessee House Bill 1376 (HB 1376), also known as Senate Bill 1413 , is a comprehensive piece of legislation enacted during the 114th General Assembly to overhaul the regulation of hemp-derived cannabinoid products (HDCPs) in the state. Signed into law by Governor Bill Lee on May 21, 2025, the bill addresses growing concerns over the unregulated sale of intoxicating hemp products, particularly those containing delta-8 THC , delta...
Post a Comment
Read more

While Europe Forgot — Cannabis in Asia, the Middle East & Africa

Cannabis through the ages: a timeless plant woven into the spiritual, medicinal, and cultural fabric of Asia, the Middle East, and Africa.   While Europe Forgot — Cannabis in Asia, the Middle East & Africa Part 2 of the Cannabis Knowledge Restoration Project Ancient China Ancient India The Middle East Africa Archaeological Evidence The Pattern While Europe was forgetting its own cannabis knowledge — losing it to industrialization, colonialism, and eventually prohibition — other cultures were preserving theirs. Not just preserving it. Evolving it. Refining it. Passing it down through unbroken lineages of healers, physicians, and spiritual practitioners. In Post 1 , we established that cannabis was foundational to European medicine for 2,000 years — until it was deliberately erased in the 20th century. But that erasure was primarily a Western phenomenon. In China, cannabis has been documented for over 5,000 years. ...
Post a Comment
Read more

The European Foundation — Cannabis in Western Medicine & Alchemy

  Rediscovering 2,000 years of cannabis’ vital role in Western medicine — from ancient texts to Victorian royal approval. The European Foundation — Cannabis in Western Medicine & Alchemy Part 1 of the Cannabis Knowledge Restoration Project If you think cannabis is some foreign drug that showed up in the 1960s counterculture, you've been lied to. If you believe it's "alternative medicine" that real doctors would never touch, you've been lied to. If you assume your European ancestors would have been horrified by cannabis use, you've been lied to. The truth? Cannabis was foundational to Western medicine for over 2,000 years. It appears in the texts that trained every European physician from ancient Rome through the Victorian era . It was prescribed by royal doctors, documented by medieval nuns, studied by Renaissance alchemists, and listed in official pharmacopeias well into the 20th century. Prohibition didn't remove something dangerous ...
Post a Comment
Read more

The Cannabis Beverage Revolution: How THC Drinks Are Disrupting Big Alcohol (And Why Tennessee Shut Them Down)

THC-infused beverages are rapidly replacing alcohol for many consumers—triggering a coordinated backlash from the alcohol industry  that culminated in Tennessee’s 2025 hemp crackdown. The Cannabis Beverage Revolution: How THC Drinks Are Disrupting Big Alcohol (And Why Tennessee Shut Them Down) A Deep Dive Into the Fastest-Growing Segment of the Cannabis Industry—And the Billion-Dollar Threat That Triggered Tennessee's Crackdown Jump to: Market Explosion Alcohol Industry Threat Big Alcohol's Response Tennessee's Response Product Reality Health Comparison Market Reality Federal Complication Tennessee's Position The Future Conclusion When Tennessee transferred hemp regulation to the Tennessee Alcoholic Beverage Commission on January 1, 2026, most people assumed it was about public safety or protecting children. But the real story is far more revealing: it's about protecting the alcohol ind...
Post a Comment
Read more

A Comprehensive Look at U.S. Cannabis Tax Revenue

  Marijuana Tax Revenue In Legal States A Comprehensive Look at U.S. Cannabis Tax Revenue Here’s a comprehensive look at how much tax revenue U.S. states with legal marijuana markets are generating — collectively and by state — and a note on what states without legal recreational marijuana are potentially missing out on. 📊 Total Tax Revenue from Legal Marijuana in the U.S. 💰 Cumulative Revenue Since 2014 (Adult-Use Only): States with legal adult-use marijuana have generated about $24.7 billion + in total state tax revenue from recreational sales since markets launched in 2014. In 2024 alone, these states collectively brought in more than $4.4 billion — the highest annual total recorded so far. This revenue comes from excise taxes, retail sales taxes, and other cannabis-specific levies imposed by states on licensed marijuana sales. 🗺️ 2023 State Tax Revenue Breakdown (Adult-Use Cannabis) These figures are approximate totals for 2023 adult-use canna...
Post a Comment
Read more